NCT05854498 2026-04-02Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal CancerUniversity of Wisconsin, MadisonPhase 2 Recruiting50 enrolled
NCT07123441 2025-08-14A Study on the Efficacy and Safety of Irinotecan Liposome (II), 5-FU/LV in Combination With Bevacizumab for the Treatment of Advanced Colorectal CancerFudan UniversityPhase 2 Not yet recruiting300 enrolled